Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
以银翘解毒颗粒为阳性对照评价参果老年感冒颗粒治疗体虚感冒(气虚肺热证)安全性、有效性的临床试验
[Translation] Clinical trial using Yinqiao Jiedu granules as a positive control to evaluate the safety and efficacy of Shenguo Lao Nian Gan Gan Granules in the treatment of body deficiency cold (Qi deficiency and lung heat syndrome)
对参果老年感冒颗粒治疗中老年体虚感冒(气虚肺热证)的安全性及有效性做出初步评价
[Translation] To make a preliminary evaluation on the safety and effectiveness of Shenguo Elderly Cold Granules in treating middle-aged and elderly people with physical weakness and cold (Qi deficiency and lung heat syndrome)
100 Clinical Results associated with Shaanxi Tianfang Technology Co., Ltd.
0 Patents (Medical) associated with Shaanxi Tianfang Technology Co., Ltd.
100 Deals associated with Shaanxi Tianfang Technology Co., Ltd.
100 Translational Medicine associated with Shaanxi Tianfang Technology Co., Ltd.